Carlsquare advised Odinwell AB, a listed Swedish Medtech company on its rights issue of units. The transaction marks another ECM-transaction for Carlsquare in Sweden and helps accelerate Odinwells development within wound care monitoring.
Odinwell AB is a Swedish medtech company, listed on Spotlight Stock Market in Stockholm, that develops a patented optical technology for monitoring and assessing covered wounds. Specifically, Odinwell develops smart sensors for wound care dressings and solutions for monitoring various factors such as bacterial growth or bleeding, which are associated with improved wound care and save time for healthcare professionals.
Odinwells rights issue of units was carried out in early April 2025 during rough markets with Trumps tariffs decreasing the markets risk willingness. Regardless, Odinwell succeeded in raising capital despite unfavorable market conditions. Thanks to this, the company now has the resources to advance the development of advanced wound care and has strengthened its capacity to further accelerate and refine its sensor technology.
Carlsquare acted as the exclusive financial advisor to Odinwell AB in their rights issue of units.
